Characterizing PSMA heterogeneity in prostate cancer and identifying clinically actionable tumor associated antigens in PSMA negative cases https://www.nature.com/articles/s41598-025-06393-z

Increased antiandrogen enzalutamide sensitivity via altering prostate cancer stem cell traits through modulating the androgen receptor-mediated CDR1/circCDR1-AS/miR-1290/BMP4 signaling https://www.nature.com/articles/s41388-025-03482-1

Decoding MUC1 and AR axis in a radiation-induced neuroendocrine prostate cancer cell-subpopulation unveils novel therapeutic targets https://www.nature.com/articles/s41420-025-02597-4

Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer https://www.nature.com/articles/s41467-025-60654-z

ZFHX3 is integral to androgen/AR signaling involving protein association with AR in prostate cancer cells https://www.nature.com/articles/s41598-025-05659-w